Detalhe da pesquisa
1.
Targeting of the WT191-138 fragment to human dendritic cells improves leukemia-specific T-cell responses providing an alternative approach to WT1-based vaccination.
Cancer Immunol Immunother
; 66(3): 319-332, 2017 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-27896368
2.
Impaired T cells and "memory-like" NK-cell reconstitution is linked to late-onset HCMV reactivation after letermovir cessation.
Blood Adv
; 8(11): 2967-2979, 2024 Jun 11.
Artigo
Inglês
| MEDLINE | ID: mdl-38315873
3.
Identification of novel canonical and cryptic HCMV-specific T-cell epitopes for HLA-A∗03 and HLA-B∗15 via peptide-PRISM.
Blood Adv
; 8(3): 712-724, 2024 02 13.
Artigo
Inglês
| MEDLINE | ID: mdl-38127299
4.
CD4+ T cells are the major predictor of HCMV control in allogeneic stem cell transplant recipients on letermovir prophylaxis.
Front Immunol
; 14: 1148841, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37234158
5.
Loss of serum and glucocorticoid-regulated kinase 3 (SGK3) does not affect proliferation and survival of multiple myeloma cell lines.
PLoS One
; 10(4): e0122689, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-25837824
6.
Combining dasatinib with dexamethasone long-term leads to maintenance of antiviral and antileukemia specific cytotoxic T cell responses in vitro.
Exp Hematol
; 41(7): 604-614.e4, 2013 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-23466625